In Brief
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
QT Vascular clinical trial exceeds patient enrolment goal
QT VASCULAR said that the clinical trial for its Chocolate® Touch drug-coated balloon in Europe and New Zealand has "substantially exceeded" its patient enrolment goal for Q4 2014. The company expects to obtain CE marking regulatory approval for the product in the second half of 2015, which would allow it to market the product in the European Union.
BBB+ rating for AG Trust's golf course holding company
Copyright SPH Media. All rights reserved.
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
